THE KOREA REGENERATIVE MEDICINE GUIDE
Conditions & evidence
Type 1 diabetes and cell replacement
Distinguishing donor islets, stem-cell-derived islets and unsupported cure claims.
“Use this guide to frame clear, indication-specific questions for your specialist consultation.”
PATIENT EVIDENCE & CONSULTATION GUIDE
Category: Conditions & evidence · Editorial Review: Updated 20 October 2026 · 3 minute read
The missing cell function
Type 1 diabetes involves loss of insulin-producing beta cells. Cell replacement research aims to restore that function, but donor islet transplantation and stem-cell-derived islet products are distinct approaches. An intravenous preparation described only as stem cells should not be assumed to replace beta cells or remove the need for insulin.
Selection and tradeoffs
Specialist islet transplantation pathways may be considered for selected adults with particularly difficult diabetes, including severe hypoglycemia problems. Immune suppression and procedure-related risks can change the balance of benefit and harm. Research into new cell sources seeks to address limitations, but an encouraging trial does not establish access to the same product in Korea.
Ask for a precise treatment identity
Request the product name, source, implantation method, authorization and eligibility criteria. Ask how insulin production, glucose control and severe hypoglycemia are measured, and whether immune suppression is required. A claim of insulin independence should include its duration, the number of patients assessed and the care needed to maintain it.
Continue essential diabetes care
Do not stop insulin or glucose monitoring because a clinic promises a cure. Bring continuous glucose monitoring summaries when available, severe hypoglycemia records, kidney results and current treatment details. Ask your endocrinologist to review the proposal and arrange a clear monitoring and emergency plan for any travel or research participation.
Continue exploring
- Acute myeloid leukemia and transplantation
- Acute lymphoblastic leukemia and transplantation
- Multiple myeloma and autologous transplant
- Prepare your consultation checklist
Sources & further reading
Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.
CONTINUE YOUR PREPARATION
Prepare for your clinical conversation.
Combine the questions in this guide with our 12-point consultation checklist or explore Seoul clinic profiles.
CELLARIUM
Knowledge before possibility.
Cellarium is an independent editorial guide to regenerative medicine and stem cell consultations in South Korea. It does not provide medical advice, diagnosis, or treatment, and is not affiliated with any clinic or hospital.
© 2026 Cellarium — The Korea Regenerative Medicine Guide. Educational reference only; always consult a qualified specialist.